Technology & Software Global On demand · 24-48h

Global Extractables and Leachables Testing Analytical Services Market Strategic Research Report

Name: Global Extractables and Leachables Testing Analytical Services Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global Extractables and Leachables Testing Analytical Servic…

$3,500 USD

Strategic Research Report

Global Extractables and Leachables Testing Analytical Services Market

$1.92B2025

7.9%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Ion Chromatography, Inductively Coupled Plasma Mass Spectrometry (ICP-MS), Headspace Gas Chromatography-Mass Spectrometry (GC-MS), Others

By Application: Pharmaceutical, Medical Devices, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Eurofins Scientific, Intertek, Pacific BioLabs, SGS SA, Sartorius, Medical Engineering Technologies Ltd, Nelson Labs, West Pharmaceutical Services, Inc, Smithers, Gateway Analytical, Merck Millipore, Sigma-Aldrich, Labcorp, Boston Analytical, Creative BioMart, Dalton Pharma Services, lucideon, Jordi Labs, RSSL, WuXi AppTec, Infinity Laboratories, ALS

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 157 pages

Market size 2025

$1.92B

Billion USD

Forecast CAGR

7.9%

2025-2032

Forecast 2032

$3.3B

Projected

Regiões

Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Extractables and Leachables Testing Analytical Services market size is predicted to grow from US$ 1,921 million in 2025 to US$ 3,236 million in 2032; it is expected to grow at a CAGR of 7.9% from 2026 to 2032.

Extractables and Leachables Testing Analytical Services is a specialized analytical process used in various industries, particularly in the pharmaceutical, medical device, and process equipment. It involves the identification, quantification, and assessment of substances that can be extracted from a product's components (extractables) or that can leach out into the surrounding environment or into a contacting substance (leachables) during the product's normal use, storage, or processing. This testing is crucial for ensuring product quality, safety, and compliance as it helps to determine if any potentially harmful or unwanted substances are being released, which could impact the integrity of the final product, the health of consumers, or the performance of the associated system.

Global key Extractables and Leachables Testing Analytical Services players cover Eurofins Scientific, Intertek, Pacific BioLabs, SGS SA, Sartorius, etc.

This report presents a comprehensive overview of the global Extractables and Leachables Testing Analytical Services market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Ion Chromatography
Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
Headspace Gas Chromatography-Mass Spectrometry (GC-MS)
Others

Segment by Application

Pharmaceutical
Medical Devices
Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Extractables and Leachables Testing Analytical Services market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Pharmaceutical, Medical Devices, Others evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Extractables and Leachables Testing Analytical Services Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 7.9%

Regional growth momentum

Market share by segment

Key metrics

Base value

$1.92B

2025

Forecast

$3.3B

2032

CAGR

7.9%

2025–2032

Regiões

global

Key companies

Eurofins ScientificIntertekPacific BioLabsSGS SASartoriusMedical Engineering Technologies LtdNelson LabsWest Pharmaceutical Services, Inc

Segments covered in this report

By Type

Ion ChromatographyInductively Coupled Plasma Mass Spectrometry (ICP-MS)Headspace Gas Chromatography-Mass Spectrometry (GC-MS)Others

By Application

PharmaceuticalMedical DevicesOthers

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Ion Chromatography
3.1.3 Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
3.1.4 Headspace Gas Chromatography-Mass Spectrometry (GC-MS)
3.1.5 Others
3.1.6 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Pharmaceutical
4.1.3 Medical Devices
4.1.4 Others
4.1.5 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 Eurofins Scientific
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Intertek
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 Pacific BioLabs
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 SGS SA
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 Sartorius
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 Medical Engineering Technologies Ltd
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 Nelson Labs
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 West Pharmaceutical Services, Inc
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 Smithers
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 Gateway Analytical
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Merck Millipore
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 Sigma-Aldrich
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 Labcorp
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 Boston Analytical
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)
8.15 Creative BioMart
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2026–2032)
8.16 Dalton Pharma Services
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2026–2032)
8.17 lucideon
8.17.1 Company Overview
8.17.2 Key Products & Segments
8.17.3 Financial Performance (2023–2025)
8.17.4 Business Strategy
8.17.5 SWOT Analysis
8.17.6 Strategic Implications (2026–2032)
8.18 Jordi Labs
8.18.1 Company Overview
8.18.2 Key Products & Segments
8.18.3 Financial Performance (2023–2025)
8.18.4 Business Strategy
8.18.5 SWOT Analysis
8.18.6 Strategic Implications (2026–2032)
8.19 RSSL
8.19.1 Company Overview
8.19.2 Key Products & Segments
8.19.3 Financial Performance (2023–2025)
8.19.4 Business Strategy
8.19.5 SWOT Analysis
8.19.6 Strategic Implications (2026–2032)
8.20 WuXi AppTec
8.20.1 Company Overview
8.20.2 Key Products & Segments
8.20.3 Financial Performance (2023–2025)
8.20.4 Business Strategy
8.20.5 SWOT Analysis
8.20.6 Strategic Implications (2026–2032)
8.21 Infinity Laboratories
8.21.1 Company Overview
8.21.2 Key Products & Segments
8.21.3 Financial Performance (2023–2025)
8.21.4 Business Strategy
8.21.5 SWOT Analysis
8.21.6 Strategic Implications (2026–2032)
8.22 ALS
8.22.1 Company Overview
8.22.2 Key Products & Segments
8.22.3 Financial Performance (2023–2025)
8.22.4 Business Strategy
8.22.5 SWOT Analysis
8.22.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Extractables and Leachables Testing Analytical Services market size?

The global Extractables and Leachables Testing Analytical Services market is estimated at US$ 1.92 billion in 2025 (base year) and is projected to reach US$ 3.24 billion by 2032.

What growth rate is expected for the Extractables and Leachables Testing Analytical Services market through 2032?

The market is expected to grow at a CAGR of 7.9% from 2026 to 2032, expanding from US$ 1.92 billion in 2025 to US$ 3.24 billion in 2032, roughly 1.7 times its base-year value.

How is Extractables and Leachables Testing Analytical Services defined?

How is the Extractables and Leachables Testing Analytical Services market segmented by type?

By type, the market is segmented into Ion Chromatography, Inductively Coupled Plasma Mass Spectrometry (ICP-MS), Headspace Gas Chromatography-Mass Spectrometry (GC-MS) and Others.

What are the key applications of Extractables and Leachables Testing Analytical Services?

Key applications covered include Pharmaceutical, Medical Devices and Others.

Which companies are profiled in the Extractables and Leachables Testing Analytical Services market report?

Key players profiled include Eurofins Scientific, Intertek, Pacific BioLabs, SGS SA, Sartorius, Medical Engineering Technologies Ltd, Nelson Labs and West Pharmaceutical Services, among 22 companies covered in total.

What geographies does the Extractables and Leachables Testing Analytical Services market analysis include?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

Who should buy the Extractables and Leachables Testing Analytical Services market report?

The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical, Medical Devices and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Extractables and Leachables Testing Analytical Services market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.